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Abstract
Background: Many young people report they want to stop smoking and have tried to do so, but most of their
quit attempts fail. For adult smokers, there is strong evidence that group behavioural support enhances quit rates.
However, it is uncertain whether group behavioural support enhances abstinence in young smokers trying to quit.
Findings: A cluster randomised trial for young people trying to stop smoking to compare the efficacy of a school-
based 9 week intensive group behavioural support course versus a school-based 7 week brief advice only course.
Participants were assessed for evidence of tobacco addiction and nicotine replacement therapy (NRT) was used if it
was deemed appropriate by the therapist. Both types of course aimed to recruit approximately one hundred
participants from approximately ten schools.
The primary outcome was successful quitting at 4 weeks after quit day judged according to the Russell standard.
Had the trial been completed, abstinence at 6 months after quit day and the relationships between successful quit
attempts and 1) psychological assessments of dependence prior to quitting 2) salivary cotinine concentration prior
to quitting and 3) sociodemographic characteristics would also have been assessed. The proportion of participants
who stopped smoking in each arm of the trial were compared using Chi square tests.
The trial was stopped shortly after it had started because funding to support the therapists running the stop
smoking group behavioural support programme was withdrawn. Only three stop smoking courses were completed
(two group support courses and one brief advice pharmacotherapy course). Seventeen participants in total entered
the trial. At the end of the courses, one participant (10%) attending the group support programme had stopped
smoking and no participant attending the brief advice programme had stopped smoking.
Discussion: The trial was stopped so we were unable to determine whether group support helped more young
people to stop smoking than brief advice. Engagement and recruitment of participants proved much more difficult
than had been anticipated. Fifteen of the seventeen participants reported that quitting smoking was either pretty
important or very important to them. Thus, the stop smoking success rate could, nevertheless, be considered
disappointing.
Trial registration: Current Controlled Trials ISRCTN25181936
Background
The trial outlined in this study protocol aimed to com-
pare smoking cessation success rates of QUIT Break
Free intensive stop smoking group support courses for
young people, with brief advice for young people. The
UK charity QUIT developed the smoking cessation
group support programme for young people. It is based
on the Maudsley Hospital Smokers Clinic approach
developed by Hajek and colleagues [1] but also draws
on Bandura’s social learning theory [2]. Participants in
both arms of the trial were to be prescribed nicotine
replacement therapy (NRT) when it was assessed as
appropriate by the therapist. The trial was planned in
2005 and took place in 2007/8. It was stopped shortly
after it had started because funding for the behavioural
support programme was withdrawn and additional
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courses were completed and one brief advice course was
completed before the trial was stopped. Here we outline
the rationale underpinning the trial and the study proto-
col so other researchers working in the field of adoles-
cent smoking cessation may benefit from our
experience. Additionally, data on the recruited adoles-
cents and their outcomes are presented and a short dis-
cussion section is included which provides up to date
information on what is currently known about the effi-
cacy of behavioural support for smoking cessation
amongst adolescents.
Rationale
The trial was initiated because adolescent smoking
prevalence in the England at the time was relatively
high compared with other Western European countries
[3,4]. Nearly a quarter (23%) of 15 year olds in England
were regular smokers in that they regularly smoked at
least one cigarette per week [3]. The median consump-
tion of 15 year old smokers was 6 cigarettes per day
[3]. Most young people who quit smoking in the UK
were (and still are) given little or no advice on how to
do so from a health professional [5,6] indicating unmet
treatment need. When smoking cessation support was
offered to young people in the UK, it was commonly
provided in the form of stop smoking groups together
with or in the absence of nicotine replacement therapy
(NRT).
The aim of the original study was to compare inten-
sive group support with no intervention. However,
shortly after the original study had begun, the Medicines
and Healthcare Regulatory Authority changed the
license of NRT to allow its prescription to young people
aged 12 years and over. QUIT felt many young people
they worked with showed evidence of tobacco addiction
and decided, on the change of license, to offer NRT
when it was judged appropriate. As a consequence of
this and the change in licence of NRT, the intended aim
of the trial was to compare group support (plus NRT
when appropriate) with an unsupported quit attempt
(plus NRT when appropriate). Most UK adolescents
who use NRT buy it over the counter and receive mini-
mal advice on its use. However, the QUIT therapists felt
it was inappropriate to offer NRT and not supervise its
use amongst young people. Therefore, the final study
protocol which is reported here planned to contrast
intensive group support with very brief advice on how
to quit initially followed by additional supervision which
f o c u s e dp r i m a r i l yo nt h es a f eu s eo fN R T .B o t ht h e
intervention course and brief advice course were confi-
dential and non-judgmental in keeping with all the stop
smoking courses that are delivered by QUIT.
Study protocol
Trial Objectives
Aim
To examine whether intensive group support was more
effective than brief advice for young people trying to
stop smoking.
Objectives
1) To measure smoking abstinence at 4 week and 6
month follow ups in both the group support programme
(intervention arm) and brief advice programme (control
arm).
2) To investigate the relationships between the likeli-
hood of successful smoking cessation and a) baseline
tobacco dependence and b) socio-demographic
characteristics.
Methods
The trial design
The trial reported here is a school based cluster rando-
mised trial that aimed to contrast intensive group sup-
port (with or without NRT) with brief initial advice on
how to quit followed by brief safety monitoring of
smoking cessation pharmacotherapy.
Eligibility criteria
In order to be eligible for enrolment into this trial, par-
ticipants were required to meet all of the following
inclusion criteria:
1. Attended a school that had been recruited to the
trial.
2. Smoked at least one cigarette per week and was
willing to attempt to stop smoking within two to
four weeks.
3. Was deemed by the QUIT therapist to be suitable
for smoking cessation support.
4. Was willing to attend a stop smoking course
which was to be held on school premises and run
during school hours, accepted that the course could
either be group behavioural support or brief advice
only and was willing to participate in the trial. Stu-
dents who did not want to participate in the trial
were allowed to attend for group behavioural sup-
port/brief advice and receive NRT if prescribed.
5. Was willing to provide her/his contact details so
that she/he could be followed up. Students who did
not want to give their contact details were not eligi-
ble to participate in the trial but were allowed to
attend for group behavioural support/brief advice
and receive NRT if prescribed.
6. Had a signed and dated a consent/assent form.
Pupils provided their own consent if they were at
least 16 years old or were 11-15 years old and
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their own decisions regarding their health care.
Pupils who were 11-15 years old who were judged
by the therapist not to be competent to provide
their own consent were required to obtain a signed
and dated consent form from their parent/guardian.
A signed and dated consent/assent form indicated
the young person or her/his parent/guardian under-
stood all aspects of both types of smoking cessation
programme (group support course and brief advice
course) and consented to participate in the research
project (trial). Consent was obtained before pupils
knew which arm of the trial they had been allocated.
Recruitment of schools
The smoking cessation lead in the local PCT and/or the
local QUIT Break Free Regional Project Managers
(RPMs) selected the schools to invite into the trial and
the RPMs approached and recruited schools to the trial.
RPMs discussed with the head of school or a representa-
tive of the head, the aims of the trial, the two different
types of stop smoking courses, advertising of the stop
smoking courses and the trial, participant recruitment,
consent of parents and consent/assent of participants.
These discussions were supported by information sheets.
Schools were recruited if they were willing to run a
stop smoking course during school time on school pre-
mises and accepted they may have been allocated a
group support course or a brief advice course.
Participant recruitment
The stop smoking courses were advertised in the school
newsletter and on the school website as soon as schools
agreed to become involved in the trial. The advertise-
ments informed parents that a 7-9 week stop smoking
c o u r s ew a st ob er u ni nt h es c h o o lo naw e e k l yb a s i s
and the success of the stop smoking courses was to be
evaluated by researchers. The advertisements also
included the contact details of an RPM so that the
wishes of parents who did not want their 11-15 year old
children to become involved in the stop smoking
courses and/or the trial would be upheld. Parents were
encouraged to contact the RPM to discuss the stop
smoking courses. During these conversations, the RPM
outlined the two types of smoking cessation courses and
e m p h a s i s e dt h a tt h et y p eo fc o u r s et ob er u ni ne a c h
school was to be decided randomly by researchers from
the universities of Warwick and Birmingham.
Training of smoking cessation therapists
The stop smoking courses for trial participants were
delivered by RPMs. All the RPMs had received in-house
training on running smoking cessation groups for young
people. They had also attended a two day external
course based on the Maudsley Hospital Smokers Clinic
approach [1] which provided training on 1) how to pre-
pare young people who want to stop smoking 2) the use
of specialised forms of group-oriented activities 3) with-
drawal oriented therapy which aims to help young peo-
ple who smoke to overcome the effects of nicotine
deprivation.
Taster session
After a period for consideration of whether to join the
course by both parents and children, the RPMs invited
young smokers who wanted to give up smoking to
attend a taster session (Session 1). Recruitment of parti-
cipants was done through publicity, personal contacts
and word of mouth. In the taster session, students were
told that a weekly stop smoking course would be run in
their school and that the success of the course would be
evaluated by researchers from the universities of War-
wick and Birmingham. Students were not told at this
stage what type of stop smoking course would run in
their school. The RPMs explained the nature of the two
stop smoking programmes and explained the choice of
course was random. The implications of the trial were
also outlined. Participants were told that in later ses-
sions they would be asked to provide their contact
details and complete questionnaires. They would also be
invited to participate in exhaled carbon monoxide moni-
toring and saliva cotinine monitoring. The ground rules
of the courses and the trial were also discussed and
RPMs explained to attendees at the taster session that
attending the following session (Session 2) would signify
commitment to stopping smoking and attending the
course. RPMs answered any questions either within the
group or on a confidential one-to-one basis. All pupils
who attended the taster session were given an informa-
t i o ns h e e tt ot a k ea w a yw i t ht h e mt h a to u t l i n e db o t h
types of stop smoking course and the implications of
the trial. The RPM also provided her contact details so
that potential participants could contact her following
the taster session to ask questions confidentially.
Session 2
Participants were asked for their mobile phone numbers
and email addresses to enable follow up and the RPMs
provided their contact details. RPMs also asked pupils
about their medical history to ensure safe prescribing of
NRT and assessed for evidence of tobacco dependence.
Use of NRT is standard practice in NHS smoking cessa-
tion clinics and is licensed by the Medicines and Health-
care Regulatory Authority for use in young people aged
12 years and over and endorsed by the National Insti-
tute for Health and Clinical Excellence [7]. Typically,
RPMs prescribed NRT patches. The patch dose and
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pant’s smoking behaviour. However, RPMs had a free
choice of any licensed form of NRT including chewing
gum and nasal spray. Participants who were given NRT
used this for as long as they or their RPM deemed
appropriate, but typically up to 8-12 weeks as a maxi-
mum. Once all the participants had signed the consent/
assent forms during Session 2, the RPM informed them
of the type of course they had all been allocated and the
course started after that.
Intervention arm - Group behavioural support
programme
The group support programme took place over nine
weeks including the taster session and each weekly ses-
sion (30-50 minutes) provided behavioural support and
advice on how to stop smoking and included NRT man-
agement. NRT was dispensed in Session 4 to commence
on quit day (Session 5). The QUIT programme was not
based on a single theoretical approach. Session activities
and the behavioural change techniques used in the
course are shown in Table 1. The identified behavioural
techniques are classified according to a taxonomy of
behaviour change techniques [8,9] and summarised in
Additional file 1. Fidelity checks were not made.
Control arm - Brief advice course
The brief advice course took place over seven weeks
including the taster session. In Session 2, participants
were given a brief intervention (10 tips to give up smok-
ing) and NRT was dispensed for starting on quit day,
which was Session 3. Participants were subsequently
s e e no naw e e k l yi n d i v i d u a lb a s i sb yt h eR P Mf o r
approximately 5 minutes (Session 3 through to Session
7). During each five minute time slot, participants were
offered brief one-to-one support and provided with
medical management if they had decided to use NRT.
Fidelity checks were not made.
Data Collection
The RPMs collected all the data. In order to standardise
data collection, all RPMs received data collection train-
ing and were provided with a data collection protocol.
Smoking status
All participants were asked about smoking on a weekly
basis and exhaled carbon monoxide was checked weekly
in both the intervention and control arms, as is standard
practice in smoking cessation clinics.
Saliva cotinine monitoring
All trial participants were invited to provide a saliva
sample before the quit date to corroborate their baseline
questionnaire answers. Saliva cotinine samples were also
taken four weeks after the quit date to validate reported
abstinence (NRT permitting). Saliva samples were frozen
and stored prior to analysis.
Trial questionnaires
Baseline questionnaires were completed prior to quit
day to assess symptoms of addiction to nicotine, motiva-
tion to quit and sociodemographic characteristics.
Addiction to nicotine was assessed by the number of
cigarettes smoked at baseline, the Hooked On Nicotine
Checklist (HONC) [10,11], the Fagerstrom Test for
Nicotine Dependence (FTND) [12] and the Mood and
Physical Symptoms Scale (MPSS) questionnaire [13]
which were all included in the baseline questionnaire.
The MPSS questionnaire [13] which provides informa-
tion about withdrawal symptoms after quitting smoking
was also completed one week after stopping smoking.
Final questionnaires that aimed to assess the perceived
value of the course and satisfaction with the way the
course was run were completed at the end of the course.
Special provision for pupils who did not have well
developed English reading and writing skills
The RPMs worked with students who had difficulty
reading the patient information sheet and/or completing
the questionnaires, without leading participants on their
responses, to help them complete the tasks.
Concomitant medication
In accordance with the National Institute for Health and
Clinical Excellence guidance on smoking cessation phar-
macotherapy, no other pharmacotherapy for smoking
cessation was prescribed [7]. Participants continued to
use their usual medication e.g. asthma inhalers.
Safety reporting
In the event that RPMs observed moderate or severe
reactions to NRT, they would have made a clinical deci-
sion on whether to stop treatment or change the dose
or route of administration of NRT. The RPMs recorded
inter-current illnesses on a weekly basis. Had the
recorded inter-current illness contra-indicated NRT, an
immediate decision about continued use of the NRT
product would have been made.
Stopping rules/Withdrawal criteria
Participants who did not attend occasional sessions were
not excluded from the group support or brief advice
programme or the trial. Participants who stopped using
NRT or changed their NRT medication were eligible to
continue with their support programme and the trial.
Participants were only classified as withdrawals if they
told the RPM directly they wished to withdraw from the
trial.
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Session activities Behaviour Change Technique
Session 1
(Taster
session)
￿ Outline of both the group support course and the brief advice course
￿ Outline of trial including completion of questionnaires, measurement of exhaled
carbon monoxide levels and saliva cotinine levels
￿ Discussion of confidentiality
￿ Discussion of ground rules
￿ None
Session 2 ￿ Introductions
￿ Ice-breaker Game
￿ Group Agreement
￿ Commitment
￿ Health check
￿ CO reading
￿ Set QUIT date
￿ Forms (for researcher)
￿ Fill in new monitoring form
￿ Monitoring of behaviour
￿ Provide opportunities for social
comparison
￿ Biofeedback*
￿ Intention formation
￿ Specific goal setting
￿ Agree behavioural contract
Session 3 ￿ CO reading
￿ Pre Questionnaire (Research) (HONC, FTNDQ)
￿ Discussion around motivation for quitting
￿‘ Weighing up Decisions’ Handout
￿‘ Smoking Diary’ Handout
￿ Monitoring of behaviour
￿ Provide opportunities for social
comparison
￿ Biofeedback*
￿ Motivation interview
￿ Provide instruction
￿ Decision making
Provide general information and
information on consequences
Session 4 ￿ CO Reading
￿ Discussion around risk of smoking (where, when, feelings)
￿ High Risk, Low risk, No risk Activity
￿ Strategies Handout
￿ Monitoring of behaviour
￿ Provide opportunities for social
comparison
￿ Biofeedback*
￿ Behavioural information
￿ Role play
￿ Barrier identification
￿ Teach to use prompts/cues
Session 5
QUIT day
￿ CO Reading
￿ Throwing away ceremony
￿ Buddy system: discussion around strategies
￿‘ First Week without Smoking’ Handout.
￿ Discussion around physical affects and first week.
￿ Monitoring of behaviour
￿ Provide opportunities for social
comparison
￿ Biofeedback*
￿ Agree behavioural contract
￿ Provide general encouragement
￿ Buddy system*
￿ Plan social support (emotional)
￿ Relapse prevention
￿ Provide instruction
￿ Barrier identification
Session 6 ￿ 1 Week post-questionnaire (MPSS)
￿ CO Reading
￿ Congratulations/smoking status
￿ Difficulties? Lapse?
￿ Use of buddies/help lines?
￿‘ How to Survive Relapse’ Handout
￿‘ 2
nd &3
rd Week without Smoking’ Handout
￿ Monitoring of behaviour
￿ Provide opportunities for social
comparison
￿ Biofeedback*
￿ Provide general encouragement
￿ Provide feedback on performance
￿ Motivational interviewing
￿ Provide instruction
￿ Use follow up prompts
￿ Review of behavioural goals
￿ Buddy system*
￿ Plan social support (emotional)
￿ Relapse prevention
Session 7 ￿ CO Reading
￿ Best/Worst experiences so far
￿ Scratch/Win Cards (Or Handout)
￿ Monitoring of behaviour
￿ Provide opportunities for social
comparison
￿ Biofeedback*
￿ Provide general encouragement
￿ Provide feedback on performance
￿ Motivational interviewing
￿ Use follow up prompts
￿ Relapse prevention
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Six months after quit day, RPMs would have contacted
each young person who attended at least Session 2 dur-
ing which he/she gave his/her written consent/assent
and contact details (as described above). RPMs would
have telephoned or e-mailed participants to tell them
she would attend their school at a particular date and
time to follow up the course and assess their smoking
status. At this appointment, the RPM would have con-
firmed smoking status, assessed exhaled carbon monox-
ide and taken a saliva sample for salivary cotinine
measurement (NRT permitting).
Definition of end of trial
All the smoking cessation courses were to have been
completed within two years of the start date. The trial
would have been completed six months and five weeks
after the final group support course or six months and
three weeks after the final brief advice course.
Trial outcomes
Primary trial outcome
The primary outcome was quitting success at 4 weeks
post quit day, as judged according to the Russell stan-
dard [14,15], meaning intention to treat and biochemi-
cally verified. This is the standard used in the NHS.
Quitting smoking is defined as self-declared abstinence
from smoking (not even a puff) for the previous 14 days
measured at 4 weeks, confirmed by an exhaled carbon
monoxide concentration of less than 8 parts per million
and a saliva cotinine measurement of < 15 ng/ml (NRT
permitting). The Russell standard allows a two week
period of grace from quit day to accommodate lapses
[16]. Those who could not be contacted for follow up
(four weeks after quit day) were counted as smokers.
Participants who decided to stop attending the group
support course or the one-to-one brief advice course
were deemed to have either continued to smoke or
given up in their attempt to stop smoking.
Secondary trial outcomes
The secondary outcomes were 7-day point prevalence
abstinence at 4 weeks and 6 months after quit day. Pro-
longed abstinence at six months would have been mea-
sured according to the Russell standard [14] as above.
Other trial outcomes (non-efficacy)
We aimed to identify the relationships between cessation
and 1) psychological assessments of tobacco dependency,
2) salivary cotinine concentration prior to quitting 3)
sociodemographic characteristics. We also aimed to col-
lect information on participants’ reactions to the support
they received, which would have been used to develop
future support programmes for young smokers.
Trial statistical considerations
Power calculation
The power of the study was limited by practical con-
straints on the sample size. QUIT estimated they could
treat approximately 200 adolescent smokers from twenty
schools within a two year period, for which we were ori-
ginally funded. Thus, approximately 100 participants
were to be randomised to both the intervention and
control arms of the intervention.
Based on QUIT’s past experience, we estimated 15%
of participants would have stopped smoking four weeks
after quit day in the group behavioural support pro-
gramme. The effect of group support was estimated to
double abstinence based on evidence of effectiveness
f r o mt h eC o c h r a n er e v i e wo fg r o u ps u p p o r ti na d u l t s
[17]. This would mean that 7-8% of the brief advice
course participants would have stopped smoking at four
weeks after quit day. A sample of around 500 would
have been needed to give 80% power to exclude a differ-
ence of this magnitude. Thus, the study as planned had
an unavoidable risk of a type II error.
Table 1 Group support course outline and behaviour change techniques 89 (Continued)
Session 8 ￿ CO Reading
￿ Smoking status/Feeling?
￿ Show blank certificates
￿ Do people feel healthier? Discuss
￿ Positive Body Mapping
￿ Monitoring of behaviour
￿ Provide opportunities for social
comparison
￿ Biofeedback*
￿ Provide feedback on performance
￿ Use follow up prompts
￿ Motivational interviewing
￿ Relapse prevention
￿ Provide information on consequences
Session 9 ￿ CO Reading
￿ Smoking Status/Feeling?
￿ Saliva Cotinine
￿ Party and Certificates
￿ Monitoring of behaviour
￿ Provide opportunities for social
comparison
￿ Biofeedback*
￿ Provide general encouragement
￿ Provide feedback on performance
￿ Provide contingent reward
￿ Use follow up prompts
*From the taxonomy outlined in 2009
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Block randomisation using blocks of four, stratified by
RPM (n = 3) was used to allocate schools to the inter-
vention or control arms. Concealed allocation was
employed. Each RPM recruited the schools and tele-
phoned the researchers as soon as the schools were
recruited. The researchers, in turn, placed the school
name next to the next free slot on the randomisation
list which had been generated using random number
tables by the researchers and telephoned the RPMs with
the result of the randomisation. The RPMs had no
knowledge of the allocation sequences and the research-
ers no knowledge or involvement with the schools.
Analysis
The analysis compared the proportion of participants
who stopped smoking in both arms of the trial (those
who received group support and those who received
brief advice) using the Chi square test. However, the
small number of participants limits the value of con-
ducting this test. Rate ratios and 95% Confidence Inter-
vals would have been calculated using standard
formulae. However this was not possible as no partici-
pant stopped smoking on the brief advice course.
The possible effects of nicotine dependence and other
predictors of smoking abstinence would have been
examined by regression models.
Ethics and Research Governance
The study complied with the principals of the Declara-
tion of Helsinki (1996) and was approved by the
National Research Ethics Service (07/H0718/45) and
local NHS Research and Development offices. We also
complied with ICH-GCP Guidelines over the reporting
of adverse events, serious adverse events and suspected
unexpected serious adverse reactions.
Monitoring and audit
The specific duties and responsibilities of the RPMs and
principal investigator were outlined in a signed formal
agreement between representatives of the employing
organisations.
Quarterly reviews were undertaken in order to ensure
young peoples’ consent/assent was always sought and
gained, the inclusion and exclusion criteria were exer-
cised and the recommendations regarding NRT use
among young people adhered to.
The electronic data would have been examined for
consistent and logical within-person responses and these
checks would have been used to ensure the data were
clean. When required, the original questionnaires would
have been re-examined and the electronic data amended
if inaccurate.
Data protection and confidentiality
Data were kept in accordance with the Data Protection
Act in order to protect patient confidentiality and
ensure appropriate follow up. No one outside the trial
team had access to either the case report forms or the
database other than approved auditors from a research
ethics committee, NHS Research and Development.
Results
Parental response to the initiative and trial
No parent from any of the three participating schools
indicated they did not wish their child/children to parti-
cipate in either of the stop smoking courses or the trial.
Recruitment to the trial
All pupils who attended the stop smoking courses were
deemed by their therapist to be competent to provide
their own consent, were willing to enter the trial and
provided their contact details in order that they could
be followed up. No student who received group support
or brief advice opted out of participating in the trial.
Baseline characteristics of study participants
Two group support courses containing ten participants
in total and one brief advice course containing seven
participants were initiated and completed before the
trial was stopped. All courses that were initiated were
completed. The baseline characteristics of the partici-
pants are shown in Table 2.
The RPMs found it much more difficult to recruit
participants than they had anticipated even though the
three courses were run in different schools. Recruited
participants tended to be members of the same friend-
ship groups. As a consequence, most of the study parti-
cipants in each school were in the same school year and
had similar ages.
Relatively few participants on either course were pre-
scribed NRT (group support n = 1; brief advice n = 3).
This finding may have been related to the observation
that 75% of participants who answered the relevant
question thought it would be fairly or very easy to quit
smoking if they wanted to. No moderate or severe reac-
tions to NRT were observed.
Even though participants did not know which arm of
the trial they had been allocated before they consented
to participate in the trial, the smoking behaviour and
biological assessments of dependence of participants
appeared, on average, to differ markedly between the
two types of smoking cessation course. Participants
attending the brief advice course smoked on average
more than four times the number of cigarettes per week
and had saliva cotinine levels that were almost twice as
high. They also appeared as expected, given the differ-
ence in the mean number of cigarettes smoked by parti-
cipants, on average more dependent on cigarettes as
judged by the FNTD and the HONC. Psychological
assessments of dependence of attendees on the two
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appear to vary according to assessment tool. Thus, parti-
cipants on the group support courses appeared to have
low psychological dependence on tobacco and smoking
as judged by the FTND but their mean HONC score
indicated they may have been more dependent on cigar-
ettes than might have been expected given the relatively
low mean number of cigarettes smoked per week.
Outcomes
The outcomes are summarised in Table 3. Only one per-
son sustained abstinence for 4 weeks. She was 14 years old,
smoked 19 cigarettes a week, and scored low dependence
on the FTND. There was no difference in the proportion
of participants who stopped smoking in each arm of the
trial as judged by the Chi square test. However, the small
number of participants limits the value this test. Data were
not available 4 weeks post quit day for one participant in
each arm of the trial as they did not attend the final ses-
sion. These two participants were deemed to have either
continued to smoke or given up in their attempt to stop
smoking. It was not possible to calculate rate ratios and
95% Confidence Intervals as no participant stopped smok-
ing on the brief advice course.
Table 2 Baseline characteristics
Group support (Intervention) Brief advice course (Control)
Number of courses 2 1
Number of participants 10 7
Females (%) 5 (50) 7 (100%)
Age years (SD) 14.4 (0.7) 14.7 (0.5)
Mean number of cigarettes smoked per week (SD) 26 (17) 113 (48)
Baseline salivary cotinine (ng/ml) 85 (78) 160 (41)
Number prescribed NRT 1 (10%) 3 (43%)
Previous quit attempt 4 (40%) 6 (86%)
How important is it that you quit on this course? Not important = 0
Slightly important = 2 (20%)
Pretty important = 8 (80%)
Very important = 0
Not important = 0
Slightly important = 0
Pretty important = 4 (57%)
Very important = 3 (43%)
How easy or difficult would it be for you to quit smoking if you wanted to? Very difficult = 0
Fairly difficult = 1 (10%)
Fairly easy = 4 (40%)
Very easy = 5 (50%)
Don’t know/Missing = 0
Very difficult = 1 (14.3%)
Fairly difficult = 1 (14.3)
Fairly easy = 2 (28.6%)
Very easy = 1 (14.3%)
Don’t know/Missing = 2 (28.6%)
Fagerstrom Test for Nicotine Dependence Very low dependence = 7 (70%)
Low dependence = 3 (30%)
High dependence = 0
Very high dependence = 0
Very low dependence = 0
Low dependence = 2 (28.6%)
High dependence = 3 (42.9%)
Very high dependence = 2
Mean HONC score (SD) 6 (1.9) 7.3 (3.1)
(Min score = 0, max score = 10 higher scores indicate higher dependence)
Mean MPSS Mood score at baseline (SD)
(Min score = 7, max score = 35)
13.9 (4.8) 16.6 (5.8)
Table 3 Study outcomes
Group support course
(Intervention)
Brief advice course
(Control)
Number of courses 2 1
Number of participants 10 7
Mean MPSS Mood score (SD) one week after quit day (max score = 7 max score
= 35)
17.9 (6.8) 20.3 (9.3)
Difference in mean MPSS Mood score after quitting and at baseline 4.0 3.7
Mean MPSS Craving score one week after quit day (SD)(Min score = 2, Max core
= 12)
6.8 (2.3) 9.0 (2.5)
Russell standard 4-week abstinence * 1 (10%) 0 (0%)
* Chi square p = 0.39
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The randomisation of schools to intervention and con-
trol arms was not completed and only three courses
were run. The imbalance in smoking behaviour and bio-
logical assessments of dependence mean we cannot
draw valid conclusions on the effectiveness of the inter-
vention. The results were, nonetheless disappointing as
only one person managed to quit smoking even though
fifteen of the seventeen participants reported that quit-
ting smoking was either pretty important or very impor-
tant to them. Other studies have found that while young
people would like to stop smoking, this is often viewed
as a future aim rather than an immediate aim reflecting
perhaps the more pressing nature of other issues in
young people’s lives [18-23]. Gnich et al. (2008) [23]
also expressed disappointment at the relatively low suc-
cess rates of stop smoking courses for young people in
Scotland. These courses were conducted in a variety of
locations and settings including schools and some of the
interventions were similar to the intervention used in
the trial reported here. Gnich et al. (2008) [23] proposed
that if Scottish young people want and need support to
stop smoking then alternative interventions might have
greater impact.
The relatively low quitting success rate in this study
may also have been related to the recruitment process.
Even though the RPMs had prior experience of recruit-
ing young people to smoking cessation support groups,
recruitment to the trial reported here was much more
difficult than had been anticipated. Recruitment of
young people to stop smoking interventions in Scotland
was also more difficult than expected and one pilot ces-
sation project failed to recruit a single person within the
two year evaluation period [23]. Young people’s lack of
interest was cited as the reason for the failure to recruit
in the Scottish study and lack of interest may also have
applied to the trial reported here. There are two other
possible reasons for the low recruitment rate to this
trial. First, young people attending school may wish to
hide their smoking status and may not wish to identify
themselves as smokers within a school setting. Second,
although no parent indicated that they did not wish
their child/children to become involved in the stop
smoking courses or the trial, active parental engagement
with the trial was not sought. It is possible that actively
canvassing the support of parents may have resulted in
improved pupil recruitment. The RPMs in the trial
reported here found that participants tended to come
f r o mt h es a m ef r i e n d s h i pg r o u p s .T h i sm a yh a v ei n f l u -
enced the results in two ways. First, participants may
have attended the stop smoking courses to support their
friends rather than to give up smoking themselves and
this possibility could potentially be usefully explored in
other forthcoming studies and trials. Second, recruiting
friendship groups would have influenced the average age
of participants, all of whom were relatively young in this
trial. Gnich et al. (2008) [23] found that age was the
only factor positively related to successful quitting at
three month follow up.
The assumption that trial participants who dropped
out have necessarily relapsed and started to smoke again
may have negatively affected the reported adolescent
smoking cessation quit ratesi nt h i ss t u d y .G r i m s h a w
and Stanton (2010) [6] draw attention to a variety of
reasons young people are unable to attend stop smoking
courses which maybe unrelated to their smoking beha-
viour [24-27].
Even though this trial was stopped, the preliminary
results were disappointing. More encouraging findings
were recorded by Grimshaw and Stanton in their
Cochrane review of randomised control trials of smok-
ing cessation interventions for young people which
included nine school based trials [6]. Grimshaw and
Stanton (2010) [6] concluded that complex interventions
which drew on social cognitive theory and focussed on
motivational enhancement and support were the most
likely interventions to aid young people in their quit
attempts. The intervention used in this study did, how-
ever, contain elements recommended by Grimshaw and
Stanton (2010) [6].
Only one trial [28] included in the Cochrane review
conducted by Grimshaw and Stanton (2010) [6] was
based in the UK. The transfer of potentially effective
interventions from North America to the UK although
appealing may not be straightforward. Within countries,
the influence of similar cognitions on adolescent smok-
ing intentions appears relatively stable and socio-demo-
graphic characteristics such as ethnicity appear to
influence intentions through these cognitions [29]. How-
ever, an investigation of the influence of country of resi-
dence on adolescent smoking intentions found that
similar cognitions have very different influences on ado-
lescent smoking intentions in different countries [30]
suggesting the transfer of interventions from one coun-
try to another may be problematic.
The trial was stopped so we were unable to determine
whether group support helped more young people to
stop smoking than brief advice. We and others in the
UK [22,23] found it much more difficult to engage and
recruit participants than was anticipated. Hence, we
would suggest that investigating methods for engaging
and recruiting young people before setting up another
randomised control trial of smoking cessation interven-
tions for young people could be a potentially useful way
forward.
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